| 0 (0%) | 11-11 17:43 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.31 |
1-year : | 7.83 |
| Resists | First : | 5.4 |
Second : | 6.71 |
| Pivot price | 3.77  |
|||
| Supports | First : | 3.29 |
Second : | 2.74 |
| MAs | MA(5) : | 3.71 |
MA(20) : | 4.07 |
| MA(100) : | 4.05 |
MA(250) : | 4.16 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 12.1 |
D(3) : | 12.4 |
| RSI | RSI(14): 46.4 |
|||
| 52-week | High : | 10.31 | Low : | 2.52 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ RKDA ] has closed above bottom band by 32.0%. Bollinger Bands are 49.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.84 - 3.86 | 3.86 - 3.88 |
| Low: | 3.55 - 3.57 | 3.57 - 3.59 |
| Close: | 3.63 - 3.66 | 3.66 - 3.69 |
Mon, 10 Nov 2025
Is RKDA a candidate for recovery play - Weekly Market Outlook & Free Weekly Watchlist of Top Performers - newser.com
Mon, 10 Nov 2025
Is RKDA stock undervalued vs historical averages - July 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Mon, 10 Nov 2025
Arcadia Biosciences (RKDA) Q3 Earnings Beat Expectations - GuruFocus
Mon, 10 Nov 2025
Is RKDA stock trading near support levels - Quarterly Market Review & Free High Return Stock Watch Alerts - newser.com
Fri, 07 Nov 2025
Arcadia Biosciences Inc expected to post a loss of 66 cents a share - Earnings Preview - TradingView
Fri, 07 Nov 2025
Arcadia Biosciences: Q3 Earnings Snapshot - San Francisco Chronicle
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 4.3 (%) |
| Shares Short | 256 (K) |
| Shares Short P.Month | 15 (K) |
| EPS | -5.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.31 |
| Profit Margin | -139.4 % |
| Operating Margin | -103.2 % |
| Return on Assets (ttm) | -32.9 % |
| Return on Equity (ttm) | -88 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 1.56 |
| Sales Per Share | 3.94 |
| EBITDA (p.s.) | -4.79 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.71 |
| PEG Ratio | 0 |
| Price to Book value | 1.1 |
| Price to Sales | 0.92 |
| Price to Cash Flow | -0.67 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|